Emergency Alert- We Need to Respond – The U.S. Senate Threatens to Cut the DOD Prostate Cancer Research Program Budget

In my most humble opinion among the most vital and impactful program in the world, which supports prostate cancer research funding and prostate cancer research resources, is in trouble. It is the only government program that funds only prostate cancer research. All of its research funding mechanisms are designed to fund high risk and potentially [...]

Help Direct Us In Our Future Prostate Cancer Support and Advocacy Actions

Please complete this ten minute, four question, anonymous survey about your thoughts around prostate cancer support and advocacy. Click>>>  https://www.surveymonkey.com/s/CCRNTQP Your answers will help us to plan future prostate cancer support and advocacy actions on your behalf. Please feel encouraged to contact me by email at joel@malecare.org with any questions or concerns about this brief survey.

Zytiga in Québec, Radium-223 in England & Lets Change Our Antiquated Approval Nonsense

Men with metastatic castration-resistant prostate cancer (mCRPC) in Québec, Canada now have access to Zytiga (abiraterone acetate) prior to having chemotherapy. Effective February 3, 2014, the province has added ZYTIGA to the public drug formulary for the treatment of mCRPC in men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy (ADT). [...]

Go to Top